Ēriks Šmagris

2.6k total citations · 1 hit paper
9 papers, 1.8k citations indexed

About

Ēriks Šmagris is a scholar working on Epidemiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Ēriks Šmagris has authored 9 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 3 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Ēriks Šmagris's work include Liver Disease Diagnosis and Treatment (9 papers), Lipid metabolism and biosynthesis (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Ēriks Šmagris is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Lipid metabolism and biosynthesis (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Ēriks Šmagris collaborates with scholars based in United States, Denmark and Latvia. Ēriks Šmagris's co-authors include Jonathan C. Cohen, Helen H. Hobbs, Soumik BasuRay, Anne Tybjærg‐Hansen, Stefan Stender, Børge G. Nordestgaard, Heather Zhou, Thomas Vogt, Julia Kozlitina and Yang Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Ēriks Šmagris

9 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

2014 867 citations Julia Kozlitina, Ēriks Šmagris et al. Nature Genetics profile →

Peers

Countries citing papers authored by Ēriks Šmagris

Since Specialization

Citations

This map shows the geographic impact of Ēriks Šmagris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ēriks Šmagris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ēriks Šmagris more than expected).

Fields of papers citing papers by Ēriks Šmagris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ēriks Šmagris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ēriks Šmagris. The network helps show where Ēriks Šmagris may publish in the future.

Co-authorship network of co-authors of Ēriks Šmagris

This figure shows the co-authorship network connecting the top 25 collaborators of Ēriks Šmagris. A scholar is included among the top collaborators of Ēriks Šmagris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ēriks Šmagris. Ēriks Šmagris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse 2024 ·PLoS Genetics ·Ēriks Šmagris, (unknown), (unknown), (unknown), (unknown), Heather M. Brown, Niek Verweij, Charleen Hunt, Reid O’Brien Johnson, Tyler Greer, Suzanne A. Hartford, George Hindy, Luanluan Sun, Jonas B. Nielsen, Gábor Halász, Luca A. Lotta, Andrew Murphy, Mark W. Sleeman, Viktoria Gusarova	6
2	Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats 2021 ·Cellular and Molecular Gastroenterology and Hepatology ·Fei Luo, Ēriks Šmagris, Sarah A. Martin, Gonçalo Vale, Jeffrey G. McDonald, Justin A. Fletcher, Shawn C. Burgess, Helen H. Hobbs, Jonathan C. Cohen	61
3	Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis 2019 ·Proceedings of the National Academy of Sciences ·Soumik BasuRay, Yang Wang, Ēriks Šmagris, Jonathan C. Cohen, Helen H. Hobbs	217
4	Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride 2017 ·Hepatology ·Stefan Stender, Ēriks Šmagris, Bo Kobberø Lauridsen, Klaus F. Kofoed, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, L Pennacchio, Diane E. Dickel, Jonathan C. Cohen, Helen H. Hobbs	47
5	The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation 2017 ·Hepatology ·Soumik BasuRay, Ēriks Šmagris, Jonathan C. Cohen, Helen H. Hobbs	210
6	Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins 2016 ·Journal of Biological Chemistry ·Ēriks Šmagris, (unknown), Soumik BasuRay, Jonathan C. Cohen, Helen H. Hobbs	158
7	Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease breakdown → 2014 ·Nature Genetics ·Julia Kozlitina, Ēriks Šmagris, Stefan Stender, Børge G. Nordestgaard, Heather Zhou, Anne Tybjærg‐Hansen, Thomas Vogt, Helen H. Hobbs, Jonathan C. Cohen	867
8	Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis 2014 ·Hepatology ·Ēriks Šmagris, Soumik BasuRay, John Li, Yongcheng Huang, Ka‐Man Venus Lai, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs	273
9	Hepatitis B and C Virus Variants in Long-Term Immunosuppressed Renal Transplant Patients in Latvia 2005 ·Intervirology ·Irina Sominskaya, Marija Mihailova, Juris Jansons, (unknown), (unknown), Ēriks Šmagris, Uga Dumpis, (unknown), Paul Pumpens	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact